MIT-spinout NeuroBionics thinks it could one day improve the lives of millions of people who live with neurological conditions like depression, epilepsy and Parkinson’s disease. Famed investor Steve Jurvetson of Future Ventures said that if everything goes right for the 18-month-old outfit, its approach could further address “the peripheral nervous system for pain, incontinence, and a bunch of other applications.” How? With what? In contrast to these outsized ambitions, NeuroBionics’ tech is tiny. Specifically, NeuroBionics aims to pipe what it has developed — bioelectric fibers the width of a human hair — through blood vessels in the brain using a procedure similar to a stent placement to deliver neuromodulation therapy. The fibers are powered by a fairly standard implantable battery that’s shaped like an Airpod case, designed to last five to 10 years, and is used by other medical device makers for spinal cord stimulation, among other things. Read more on NeuroBionics at the link in the bio 👆 Article by Connie Loizos Image Credits: NeuroBionics #TechCrunch #technews #startup #founder #MIT #healthtech #biotech